Expression in retinal neurons of fukutin and FKRP, the protein products of two dystroglycanopathy-causative genes by Haro, Carmen et al.
Dystroglycanopathies (DGPs) are a group of minority 
congenital neuromuscular dystrophies caused by deficien-
cies in the complex process of O-mannosyl glycosylation of 
dystroglycan (DG). They are clinically and genetically hetero-
geneous diseases that are inherited in an autosomal recessive 
fashion, and whose symptoms involve a broad spectrum of 
clinical manifestations mainly affecting the skeletal muscle 
and central nervous system (CNS), with the latter including 
the brain and retina [1-3]. Recently, these diseases have been 
jointly designated in the OMIM database under the term 
“Muscular dystrophies-dystroglycanopathies (congenital with 
brain and eye anomalies),” which are abbreviated as MDDGs.
DG is the main component of the so-called dystrophin-
glycoprotein complex (DGC), a multiprotein assembly 
composed of peripheral and integral membrane proteins and 
responsible for linking the cytoskeleton of muscle and nerve 
cells to the extracellular matrix (ECM) of their resident tissue 
[4,5]. The DGC is thus crucial for the correct structure and 
function of muscle and nervous systems from early embryo-
genesis in mammals [6,7]. DG is a glycoprotein composed 
of two subunits: alpha (α-DG), which is extracellular, and 
beta (β-DG), which is transmembrane and cytoplasmic. 
These two polypeptides remain non-covalently linked and 
associated with the plasma membrane [8-10]. DG is widely 
distributed in a variety of cell types, and usually associated 
with basement membranes, such as muscle, nervous tissue, 
epithelial tissue and vascular endothelium [11-13]. The α-DG 
polypeptide is heavily and heterogeneously glycosylated by 
the addition of N- and (especially) O-glycans to its central, 
mucin-like domain [14]. Its O-linked glycan chains are essen-
tial for the interaction of α-DG with other ECM proteins, such 
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as laminin, agrin and perlecan in general [4,5], neurexin [15] 
and slit [16] specifically in the brain, and pikachurin exclu-
sively in the retina. The interaction between the latter and 
DG has been proven to be essential for the formation and 
function of ribbon synapses established at the outer plexi-
form layer (OPL) between photoreceptors (cones and rods) 
and their postsynaptic, bipolar and horizontal neurons [17]. 
Interactions between DG and ECM proteins are also crucial 
for the proper formation by Müller glia of the inner limiting 
(basement) membrane separating the neural retina from the 
vitreous humor [18,19]. Retinal symptoms derived from 
the loss of α-DG glycosylation may consequently involve 
chorioretinal atrophy, retinal dysplasia and detachment, and/
or vitreoretinal dysgenesis [20-24].
A total of 18 genes have been hitherto identified in which 
mutations cause different types of DGPs with varying degrees 
of clinical severity. With the exception of DAG1 (Gene ID 
1605; OMIM 128239), which codes for DG itself, most of 
these genes encode protein glycosyltransferases whose loss of 
function causes α-DG hypoglycosylation and thereby affects 
its function as a receptor for its ECM ligands [1,25]. The 
nomenclature for these enzymes that was recently adopted by 
Yoshida-Moriguchi and Campbell [10] is used in this work. 
The first genetic alteration identified as causative of DGPs, 
namely Fukuyama congenital muscular dystrophy (FCMD), 
was detected in Japan as an ancestral founder mutation [26] 
and was subsequently mapped on the FKTN gene (Gene ID 
2218, OMIM 607440), encoding the 461 amino-acid enzyme 
called fukutin [27]. Thereafter, a significant number of non-
Japanese patients with mutations in the FKTN gene have been 
reported, some with FCMD phenotype and others with more 
severe DGPs, such as Walker-Warburg syndrome (WWS) 
or muscle-eye-brain disease (MEB) [23,28,29], all of them 
designated as type MDDGA4 (OMIM 253800). However, 
mutations in FKTN can also cause milder DGPs that do 
not involve mental retardation, dubbed as types MDDGB4 
(OMIM 613152) and MDDGC4 (OMIM 611588), the latter 
previously designated as limb-girdle muscular dystrophy 
(LGMD) type 2M [23,24,30]. Soon thereafter, a gene 
encoding the 495 amino-acid enzyme called fukutin-related 
protein (FKRP; Gene ID 79147, OMIM 606596) was identi-
fied [31,32], which can also cause different forms of DGPs 
that are either severe with anomalies in the brain and eye 
(MDDGA5; OMIM 613153), such as WWS or MEB [22,24], 
or milder with or without mental retardation, dubbed as types 
MDDGB5 (OMIM 606612) and MDDGC5 (OMIM 607155), 
the latter also known as LGMD type 2I [30-32].
Fukutin and FKRP proteins are structurally and function-
ally related glycosyltransferases involved in the biosynthetic 
pathway leading to the extension of the α-DG O-mannosyl 
glycan core structure called M3, i.e., the phosphorylated 
O-mannosyl trisaccharide GalNAc(β1–3)GlcNAc(β1–4; P6)
Man. This pathway has so far been identified only for specific 
O-mannose residues previously added by the POMT1/POMT2 
heterodimer to Ser/Thr residues in the mucin-like domain of 
α-DG, and involves the addition by the enzyme POMGNT2 
of a molecule of N-acetylglucosamine (GlcNAc), covalently 
linked by a β1–4 bond to the O-mannose residue, presum-
ably in the endoplasmic reticulum (ER) [33,34]. Next, the 
B3GALNT2 protein adds one unit of N-acetylgalactosamine 
(GalNAc), with subsequent phosphorylation at the 6-position 
of the O-mannose residue by the enzyme POMK [34]. α-DG 
is then thought to be transported to the Golgi complex, where 
fukutin and FKRP act to sequentially add to the GalNAc 
molecule two ribitol 5-phosphate (Rbo5P) units in tandem 
from cytidine-diphosphate-ribitol (CDP-Rbo) [35,36]. There-
after, the proteins products of other DGP-associated genes 
contribute to add to this tandem the so-called matriglycan 
polysaccharide, whose presence, and especially its number 
of repeats, is essential for the binding of α-DG to its ECM 
ligands [3,10,34,37,38].
Fukutin and FKRP are believed to perform their Rbo5P 
transferase function in the Golgi complex, where they 
have been detected in human skeletal muscle cells [39,40] 
and mouse liver [35]. To study the role of DGP-associated 
proteins in vivo, several mouse models have been generated 
and characterized, which exhibit null mutations in particular 
genes encoding glycosyltransferases acting on α-DG 
[18,19,41]. These included chimeric knockout (KO) mice for 
the fukutin-encoding gene [42] and knock-down mice for the 
gene encoding FKRP [43,44]. In all these models, a partial 
or total absence of α-DG glycosylation has been unveiled, 
together with associated ocular structural and functional 
alterations resembling those existing in patients with DGPs. 
Nevertheless, the precise role of fukutin and FKRP proteins 
in the adult visual system is largely unknown, and their 
distribution pattern in the retina remains to be established. 
In this work, we have analyzed the expression of FKTN and 
FKRP at the mRNA and protein levels in the neural retina of 
several mammalian species and in cultured photoreceptors of 
the 661W cell line. Interestingly, in addition to being located 
in the ER and the Golgi complex, respectively, both fukutin 
and FKRP accumulate in the nucleus in this cell line, where 
they could play a hitherto unreported function.
Molecular Vision 2018; 24:43-58 <http://www.molvis.org/molvis/v24/43> © 2018 Molecular Vision 
45
METHODS
Animals: The adult mammalian species studied in this work 
included mice (Mus musculus, strain C57BL/6J), rats (Rattus 
norvegicus, strain Sprague-Dawley), cows (Bos taurus), and 
cynomolgus monkeys (Macaca fascicularis). All animal 
handling was performed in compliance with the rules 
set by the National Institutes of Health (USA), the ARVO 
Statement for the Use of Animals in Ophthalmic and Vision 
Research, and the European Directive 2010/63/EU. Rodents 
were held at the Universidad de Alicante animal-care facility 
and euthanized upon CO2 inhalation, followed by cervical 
dislocation. Their eyes were enucleated and stored in RNAl-
ater solution (Ambion; Austin, TX, USA). Bovine eyes were 
freshly obtained from the Alicante municipal slaughterhouse. 
Monkeys were kept as described [45] at the animal-care 
facility of the Universidad de Murcia (Spain), and their eyes 
were kindly donated by Dr. M.T. Herrero. All protocols 
and primate-handling procedures used were approved by 
the university bioethics research committee. Young adult 
monkeys were anesthetized with ketamine (10 mg/kg, i.m.) 
and then administered a lethal injection of pentobarbital 
(50 mg/kg, i.p.), and their eyeballs were immediately enucle-
ated following sacrifice. All animal eyes were kept at –80°C 
until the retinas were dissected for RNA or protein isolation. 
For immunohistochemistry, mouse eyes were fixed in 4% 
paraformaldehyde in 0.1 M sodium phosphate buffer pH 7.4 
(PB) for 1 h and then subjected to sucrose cryoprotection [46].
Cell culture: The 661W photoreceptor cell line was kindly 
provided by Dr. M. Al-Ubaidi (Department of Biomedical 
Engineering, University of Houston, TX). It was cloned from 
a retinal tumor of a transgenic mouse line that expressed the 
artificial HIT1 transgene, containing the SV40 large T antigen 
coding sequence under the control of the human inter-photo-
receptor retinol-binding protein gene (IRBP/RBP3; Gene ID 
5949, OMIM 180290) promoter [47]. These immortalized 
cells express cone molecular markers, such as opsins, trans-
ducin and cone arrestin, and lack proteins specific to rods or 
other retinal cell types, constituting a light-sensitive, homoge-
neous cell line [48,49]. The 661W cells were authenticated by 
means of short tandem repeats (STR) genotyping, and their 
genetic profile was verified to be consistent with a mixed 
FVB × C57BL/6 mouse strain of origin, as expected, and 
to carry the HIT1 transgene that makes this cell line unique 
(Appendix 1) [47,50]. The cells were grown on Dulbecco’s 
modified Eagle medium (DMEM) from HyClone (Logan, 
UT), and supplemented with 10% fetal bovine serum from 
Gibco (Grand Island, NY), 2 mM L-glutamine, and 1% 
penicillin/streptomycin (HyClone) at 37°C in a humidified 
atmosphere containing 5% CO2. Cells were expanded on 75 
cm2 flasks, and after 5–10 passages under culture conditions 
they were frozen at –80°C until RNA or protein extraction 
was performed, or else they were seeded on 24-well culture 
plates and used for immunocytochemistry when they were 
nearly confluent.
Reverse transcription (RT)-PCR: The neural retina was 
dissected out, free from the retinal pigment epithelium (RPE), 
from eyes stored in RNAlater. Total RNA was extracted from 
retinal tissue and 661W photoreceptors using the TRIzol 
reagent (Invitrogen; Carlsbad, CA) and then treated with 
DNase I using the TURBO DNA-free kit (Ambion). RNA 
from normal human retina (29 donors, both sexes, 20–60 
years at death) was purchased from Clontech BD (Mountain 
View, CA). RT reactions were performed using the RETRO-
script kit (Ambion), and subsequent PCR amplification of 
cDNA segments was performed essentially as described 
[50-52]. Primers specific to genes FKTN and FKRP of the 
different species (Table 1) were designed to bear a Tm of 
60°C and flank at least one intron of the corresponding gene. 
PCR reactions (40 μl) contained 20 ng of cDNA, forward and 
reverse primers at 0.4 μM each, the four deoxynucleotides 
(dNTPs) at 0.2 mM each, and 1 U of GoTaq DNA polymerase 
(Promega; Madison, WI). PCR products were run on 2% 
agarose gels with added SYBR Green I (Sigma-Aldrich; St. 
Louis, MO) and photographed under ultraviolet (UV) light.
Immunoblotting: Total proteins were extracted from neural 
retinas and 661W cells, as previously described [51]. Briefly, 
a volume of 20 μl of lysis buffer supplemented with protease 
inhibitors was added per 5 mg of tissue or 106 cells, and after 
incubation on ice for 15–20 min, the supernatant obtained 
upon centrifugation at 16,000 ×g at 4°C for 10 min consti-
tuted the total protein fraction. To obtain the cytoplasmic and 
nuclear protein fractions, the NE-PER kit from Pierce (Rock-
ford, IL) was used, as previously detailed [50]. Proteins were 
resolved by sodium dodecyl sulfate–PAGE (SDS–PAGE) on 
5%–20% polyacrylamide-gradient gels, and after electro-
transfer to polyvinylidene fluoride (PVDF) membranes (GE 
Healthcare, Buckinghamshire, UK), they were stained with 
SYPRO Ruby Protein Blot Stain (Molecular Probes; Eugene, 
OR) to ensure even protein loading and transfer. Immuno-
detection was performed essentially as described [45,50-52]. 
The membranes were probed sequentially with primary 
antibodies (Table 2) at 4°C overnight and with horseradish 
peroxidase-conjugated anti-IgG secondary antibodies at 
a 1:10,000 dilution for 1 h, and detection was achieved by 
means of enhanced chemiluminescence. The absence of cross 
contamination between the cytoplasmic and nuclear fractions 
was assessed by immunoblotting using antibodies to proteins 
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exclusively found in these compartments, namely β-tubulin 
III and lamin A/C, respectively.
Immunohistochemistry: Cryostat vertical sections (14–16 μm 
thick) were obtained and processed for immunohistochem-
istry, essentially as described [46,50-52]. Sections were 
subjected to single or double immunostaining with primary 
antibodies (Table 2) in PB supplemented with 1% (v/v) Triton 
X-100 (PBX) at room temperature overnight. Thereafter, the 
samples were incubated in the presence of donkey secondary 
antibodies to rabbit or mouse IgG conjugated to Alexa Fluor 
488 (green) or 546 (red) from Molecular Probes, at a 1:100 
dilution in PBX. 4’,6-Diamidino-2-phenylindole (DAPI) was 
simultaneously added at 10 μg/ml, and incubation took place 
for 1 h at room temperature with gentle shaking in the dark 
in a humidified chamber. Control samples in which primary 
antibodies were omitted and the corresponding secondary 
Table 1. Primers used for rT–PCr in This work.
Gene GenBank accession number Species Primer sequences  (5’-3’) Exon PCR product size (bp)
FKTN NM_001079802 Hu F: GGGAGTACCATTCTGGCTGA 8 150
NM_001257495 Mk R: GGAAGTCCTGCATCCTGAAA 9
XM_002689900 Bv F: GGGAGTGCGGTTCTGGCT 8 150
R: GGGAGTCCTGCATCTTGAAA 9
NM_001108667 Rt F: GGGAGTGCCCTTCTGGCT 8 150
NM_139309 Mo R: GGAAGTCCTGCATCCTGAAA 9
FKRP NM_024301 Hu F: GACCTGGGCATCTACTTGGA 4 150
R: CAAGTGGTTGCTTTCGCTGT 4
NM_001258048 Mk F: GACCTGGGCATCTACTTGGA 4 150
R: GAGGTGGTTGCTTTCGCTAT 4
NM_001099714 Bv F: TGGGACTACGATGTGGACCT 4 163
R: GGTGGTTGCTCTCGCTGTA 4
NM_001025678 Rt F: GATCTGGGCATCTACCTGGA 4 245
NM_173430 Mo R: AAGTGCTCTGGGAACTCAACA 4
The accession numbers indicated correspond to mRNA sequences deposited in the GenBank database. The sequences of forward (Fw) 
and reverse (Rv) primers used in this work are given, with indication of the exon to which each primer aligns. The PCR product size is 
indicated in the last column for each primer pair. Hu, human; Mk, monkey; Bv, bovine; Rt, rat; Mo, mouse. For the 661W cell line the 
mouse primers were used.
Table 2. Primary anTibodies used in This work.
Protein Antibody Company Catalog no.
Working dilution
IB IHC ICC
Fukutin Rabbit, polyclonal Proteintecha 18,276-1-AP 1:1,000 1:50 1:100
FKRP Rabbit, polyclonal Origeneb TA347645 1:1,000 – –
FKRP Rabbit, polyclonal AbboMaxc 620–830 – 1:50 1:100
β-Tubulin III Rabbit, polyclonal Sigma-Aldrich T3952 1:1,000 – –
Lamin A/C Mouse, 4C11 Sigma-Aldrich SAB200236 1:10,000 – –
Calreticulin Mouse, 1G6A7 Thermo Scientificd MA5–15382 – 1:1,000 –
KDEL Mouse, 10C3 Abcame ab12223 – – 1:250
GM130 Mouse, 35 BD Biosciencesf 610,822 – 1:50 1:250
β-Dystroglycan Mouse, 43DAG1/8D5 Abcam ab49515 – 1:50 –
The two first columns enlist the antigen and animal origin of each antibody, and the clone code is specified for monoclonal antibodies. 
The two central columns indicate the commercial company and antibody catalog reference. The three last columns specify the dilution 
at which each antibody was used on immunoblotting (IB), immunohistochemistry (IHC) or immunocytochemistry (ICC). aProteintech 
(Manchester, UK), bOrigene (Rockville, MD), cAbboMax (San Jose, CA), dThermo Scientific (Waltham, MA), eAbcam (Cambridge, UK), 
fBD Transduction Labs. (Franklin Lakes, NJ).
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antibodies were included were processed in parallel. Fluo-
rescence was detected using a Leica TCS SP2 confocal 
laser scanning microscope (Leica Microsystems; Wetzlar, 
Germany).
Immunocytochemistry: 661W photoreceptors were seeded on 
24-well culture plates at 75,000 cells per well and grown on 
a 5% CO2 atmosphere at 37°C for 24 h. Then the cells were 
fixed with 4% paraformaldehyde in Dulbecco’s PBS (DPBS) 
for 10 min. Thereafter, they were permeabilized in situ with 
0.2% Triton X-100 in DPBS for 10 min, and non-specific 
binding was prevented by incubation with 1% BSA in DPBS 
(blocking solution) for 1 h. Subsequently, the cells were incu-
bated with primary antibodies at the dilutions indicated in 
Table 2 in blocking solution in a humidified chamber at 4°C 
overnight. Incubation with Alexa Fluor-conjugated anti-IgG 
secondary antibodies (plus 10 μg/ml DAPI when indicated), 
controls and fluorescence detection under confocal micros-
copy were performed as indicated above. Colocalization 
was assessed with the JACoP plugin developed for the NIH 
ImageJ software. Pearson’s coefficient (PC) values were each 
calculated as the average ± SD of ten cells from micrographs 
obtained in duplicate experiments. The 661W nuclei or Golgi 
complexes were cropped before analysis. PC values can range 
from 1 to −1, with 1 standing for a completely positive corre-
lation and −1 for a negative correlation, and with 0 standing 
for no correlation (mid-range coefficients, of −0.5 to 0.5, do 
not allow conclusions to be drawn) [53].
RESULTS
The expression profile of genes encoding fukutin (FKTN) 
and FKRP is fairly unknown in the mammalian retina. To 
evaluate whether these genes are transcribed in this tissue, 
eyes from different species were enucleated, and total RNA 
was extracted from their dissected neural retinas. Total RNA 
was also isolated from cultures of the 661W mouse cell line 
of cone photoreceptors. By means of RT–PCR using specific 
primers, we determined that the FKTN and FKRP genes were 
expressed at the mRNA level in the retinas of all mammals 
studied, including rodents (mouse and rat), bovine and 
primates (monkey and human) retinas, as well as in the 661W 
cell line (Figure 1A). All PCR products obtained exhibited the 
sizes expected from the experimental design performed, and 
their DNA sequencing confirmed that they corresponded to 
the predicted cDNA fragments in all cases.
We also demonstrated by immunoblotting that the 
protein products of these two genes, fukutin and FKRP, were 
synthesized in the retina and in 661W cells, consistently with 
positive results on mRNA expression. As shown in Figure 1B, 
the fukutin and FKRP enzymes were detected in total protein 
extracts from the retina of all mammalian species analyzed, 
as well as from 661W photoreceptors. Fukutin migrated 
with an apparent molecular mass of 60 kDa, corresponding 
to the size reported by other authors [39,54,55]. Regarding 
FKRP, it migrated with an apparent molecular mass of 
55 kDa, compatible with the canonical form of the protein in 
the different species. We next investigated the intracellular 
localization of fukutin and FKRP using protein extracts from 
the cytoplasm and nucleus of the adult mouse neural retina 
and 661W cell line. As shown in Figure 1C, immunoblotting 
analysis revealed that fukutin was found in both cytoplasmic 
and nuclear fractions of the mouse retina, whereas FKRP 
was detected exclusively in the cytoplasm. However, the two 
proteins were found in both the cytoplasm and nucleus of 
661W photoreceptors. By using specific antibodies against 
β-tubulin III (an exclusively cytoplasmic protein) and lamins 
A and C (two exclusively nuclear proteins), we were able 
to evidence that in our hands, the fractionation procedure 
followed did not result in cross-contamination between the 
two subcellular fractions (Figure 1C).
Since both fukutin and FKRP were found to be expressed 
in the mouse retina and 661W photoreceptors, we subse-
quently addressed their distribution pattern in retinal sections 
and cultured 661W cells by means of confocal immunofluo-
rescence microscopy. In mouse cryostat sections immunos-
tained with an antibody specific for fukutin, we found that 
this protein was located in different retinal layers (Figure 
2A,C), although it was mainly present in the inner segments 
(IS) of photoreceptors and the outer plexiform layer (OPL). 
We also observed a weaker immunoreactivity of fukutin in 
the outer nuclear (ONL) and inner plexiform (IPL) layers, as 
well as in the inner nuclear (INL) and ganglion cell (GCL) 
layers, where it accumulated in the nuclei of several cells, 
but without colocalizing with the DNA-binding dye, DAPI 
(Figure 2B,C). This analysis confirmed that in addition to the 
cytoplasm, fukutin was present in the nucleus of some retinal 
cell types, in keeping with the results obtained by immunob-
lotting (Figure 1C). Yet, the cytoplasmic distribution pattern 
of fukutin did not resemble that of the Golgi complex, as could 
be expected (see above). Furthermore, when we performed a 
double immunostaining for fukutin and GM130, a structural 
protein of the Golgi widely used as a marker for this organelle 
(Figure 2D), we did not observe colocalization, as illustrated 
in Figure 2E-G. Since endogenous fukutin had been previ-
ously located in the ER in a limited number of tumor cell 
lines [55,56], we next performed a double immunostaining 
using antibodies against fukutin and calreticulin, a chaperone 
aiding in the correct folding of glycosylated proteins in the 
ER that is often used as a marker for this organelle (Figure 
2H). As a result, we detected an extensive colocalization of 
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Figure 1. Expression of FKTN and 
FKRP at the mRNA and protein 
levels in the mammalian retina 
and 661W photoreceptor cell line. 
A: Total RNA was extracted from 
the neural retina of the indicated 
species and 661W cells, and the 
expression of the mRNAs encoded 
by the two genes was detected by 
RT–PCR using specific primers. 
PCR products were verified by 
DNA sequencing. B: Immunoblot-
ting analysis of fukutin and FKRP 
expression was performed on total 
protein extracts (100 μg/lane) of 
the neural retina of the indicated 
species and 661W cells. C: Immu-
noblotting analysis of total (T), 
cytoplasmic (C) and nuclear (N) 
protein fractions extracted from the 
mouse neural retina and 661W cells 
(50 μg/lane) was performed using 
antibodies against fukutin, FKRP, 
β-tubulin III (a cytoplasmic control 
protein), and lamin A/C (two 
nuclear control proteins). The sizes 
of the bands obtained are given on 
the right side of each panel.
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both proteins (Figure 2I, yellow), both in the IS of photo-
receptors (Figure 2J) and their presynaptic terminals in the 
OPL (Figure 2 K), i.e., the two areas of photoreceptors where 
the ER is known to be mainly present [57].
We then investigated the fukutin intracellular distribu-
tion pattern in 661W photoreceptor cells. As shown in Figure 
3A,B, in this cell line fukutin was present both in the cyto-
plasm and the nucleus, supporting the results obtained by 
immunoblotting (Figure 1C). In the nucleus of 661W cells, 
fukutin exhibited a dense immunoreactivity, appearing as a 
dotted pattern, but again without colocalization with DAPI 
(Figure 3B,C; PC=0.16±0.03). This protein was found to be 
widely distributed in the cytoplasm of 661W cells, but without 
colocalizing with the Golgi marker GM130 (Figure 3D), as 
found in double immunostaining experiments performed 
on cultured cells (Figure 3E,F; PC=0.11±0.05). Instead, and 
as in retinal sections, fukutin displayed a location that was 
compatible with that of the ER. To investigate this possibility, 
we performed a double immunostaining using antibodies 
specific to fukutin and KDEL (Figure 3G), a well-known 
signal sequence retaining numerous proteins in the ER that 
is hence frequently used as a marker for this organelle. As 
a result, we detected a significant colocalization of fukutin 
and KDEL (Figure 3H,I; yellow; PC=0.58±0.02), indicating 
that part of the fukutin protein was concentrated in the ER 
in this cell line.
We next addressed the expression pattern of FKRP in 
the mouse retina and the 661W photoreceptor cell line. We 
observed that FKRP was present in different layers of the 
retina (Figure 4A,C), accumulating in the IS of photorecep-
tors and additionally in the OPL, INL and GCL. This protein 
appeared excluded from the nuclei of all retinal cell types, 
which are shown stained with DAPI in Figure 4B,C. This 
analysis confirmed that FKRP was expressed exclusively in 
the cytoplasm in the mouse retina, in agreement with our 
results obtained by immunoblotting in this tissue (Figure 1C). 
Since this protein had been previously found in the Golgi 
complex in human skeletal muscle [39,40] and mouse liver 
[35], we next performed a double immunostaining using 
antibodies against FKRP and the Golgi marker GM130 
(Figure 4D). The results obtained revealed a colocalization 
of these two proteins (Figure 4E, yellow), both in the IS of 
photoreceptors (Figure 4F, arrows) and in virtually all cells 
in the INL (Figure 4G, arrows) and in the GCL (Figure 4E, 
arrows). No colocalization was seen for FKRP with KDEL 
or calreticulin (data not shown), which made it unlikely that 
FKRP resided in the ER in addition to the Golgi. To shed 
light on the localization of the FKRP enzyme in the OPL, we 
performed a double immunostaining with antibodies against 
FKRP and β-DG (Figure 4H-J), the latter being known to 
be present in the presynaptic membrane of photoreceptors 
[58,59]. As shown, a strong colocalization was found between 
these two proteins at the axon terminals of photoreceptors 
(Figure 4J), which indicated that FKRP resided in their 
plasma membrane, possibly in close proximity to β-DG.
FKRP was also visualized in both the cytoplasm and 
nucleus of 661W cells, supporting the results obtained by 
immunoblotting (Figure 1C). Like fukutin, this enzyme 
exhibited a significant intranuclear immunoreactivity (Figure 
5A), appearing as a dotted pattern without colocalization 
with DAPI (Figure 5B,C; PC=0.18±0.04). In the cytoplasm, 
FKRP distributed in highly immunopositive elements clus-
tered in one pole of every nucleus stained with DAPI (Figure 
5B,C), i.e., in a localization compatible with that of the Golgi 
complex. To investigate this possibility, we performed a 
double immunostaining using specific antibodies against 
FKRP and the Golgi marker, GM130 (Figure 4D). The 
results obtained revealed a significant colocalization of both 
proteins (Figure 5E,F; PC=0.59±0.04), indicating that part 
of the FKRP protein concentrated in the Golgi in this cell 
line. In contrast, double immunolabelings for FKRP and the 
ER markers KDEL or calreticulin revealed a total absence of 
colocalization in the 661W cell line (data not shown).
DISCUSSION
FKTN and FKRP genes encode two related protein glyco-
syltransferases that act sequentially to transfer two Rbo5P 
molecules from CDP-Rbo to the phosphorylated core M3 
glycan of α-DG. In this process, fukutin adds the first Rbo5P 
unit and FKRP the second, the two Rbo5P units becoming 
linked between them and to the GalNAc residue of core M3 
by phosphodiester bonds [35,36]. Subsequently, alternating 
Xyl and GlcA residues are repetitively appended to the tandem 
Rbo5P scaffold to constitute the so-called matriglycan, i.e., 
the α-DG polysaccharide moiety directly involved in ligand 
binding [10,36]. These pathways of α-DG O-glycosylation are, 
however, essentially unknown in the retina, and in particular 
only mRNA expression of the FKTN gene has been demon-
strated by means of in situ hybridization in the human fetal 
retina [21]. Yet, we have recently reported in the adult retina 
of several mammalian species the expression, at the mRNA 
and protein levels, of DGP-causative genes encoding POMT1, 
POMT2 and POMGNT1 [50], three glycosyltransferases 
acting on α-DG. POMGNT1 is responsible for catalyzing the 
second step in the synthesis of α-DG glycans designated as 
cores M1 and M2 (but not M3) by covalently attaching, with 
a β1–2 linkage, one unit of GlcNAc to O-mannose residues 
previously added by the POMT1/POMT2 heterodimer to Ser/
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Figure 2. Immunolocalization of fukutin in the mouse retina. Double immunostainings were performed on mouse retinal sections for 
fukutin (A, C, E, I; green), the specific Golgi complex marker GM130 (D, E; red), and the specific ER marker calreticulin (CALR; H, I; 
red). Enlarged views in F and G correspond to boxed areas in E, and enlarged views in J and K to boxed areas in I. Nuclei stained with 
DAPI are shown in blue (B, C, F, G, J and K). Fukutin immunoreactivity was found in the cytoplasm and nucleus of cells in the INL and 
the GCL of the mouse retina, but without colocalizing with DAPI (C, arrowheads). However, colocalization of fukutin with calreticulin was 
observed in the IS of photoreceptors and the OPL (I-K), but without noticeable colocalization with GM130 (E-G). Asterisks in D and H 
indicate non-specific immunostaining of retinal vessels with secondary antibodies to mouse IgG. IS=inner segments; ONL=outer nuclear 
layer; OPL=outer plexiform layer; INL=inner nuclear layer; IPL=inner plexiform layer; GCL=ganglion cell layer. Each bar equals 20 μm, 
except in F, G, J and K: 10 μm.
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Figure 3. Immunolocalization of fukutin in the 661W photoreceptor cell line. Cells were immunostained with specific antibodies against 
fukutin (A, B, E; green), the Golgi marker GM130 (D, E; red), and the ER marker KDEL (G, H; red). Nuclei stained with DAPI are shown 
in blue (B). Enlarged views in C, F and I correspond to boxed areas in B, E and H, respectively. Fukutin immunoreactivity was found in 
the cytoplasm and nucleus of 661W cells, and colocalized with KDEL in the cytoplasm (H, I, yellow), but not with GM130 (E, F). Each bar 
equals 20 μm, except in C, F and I: 5 μm. 
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Thr residues [10]. We have recently located these two proteins 
in the ER of 661W cells (data not shown), whereas POMGNT1 
was found to reside in the Golgi complex of photoreceptors in 
the mouse retina and 661W cell line [50].
In the present work, we evidenced expression of the 
mRNAs of the FKTN and FKRP genes and their protein prod-
ucts in the neural retina of all mammalian species studied, 
ranging from rodents to primates, as well as in the 661W 
photoreceptor cell line (Figure 1). Expression of the FKTN 
gene mRNA has been reported in a wide variety of fetal and 
adult human tissues, with higher levels in the normal heart, 
brain, skeletal muscle and pancreas [26,27,54,60-62]. At the 
protein level, fukutin has been previously detected in multiple 
human organs, such as skeletal muscle, the brain and spinal 
cord in the CNS, and also in the skin, heart, liver, pancreas, 
kidney and uterine cervix [39,54,55,60,61]. Additionally, in 
Figure 4. Immunolocalization of FKRP in the mouse retina. Double immunostainings were performed on mouse retinal sections for FKRP 
(A, C, E, H, J; green) and the Golgi complex marker GM130 (D, E; red) or β-dystroglycan (β-DG; I, J; red). Enlarged views in F and G 
correspond to boxed areas in E, and the boxed area in J is shown enlarged in the lower right inset. Nuclei stained with DAPI are shown in blue 
(B, C, F-J). FKRP showed immunoreactivity in the photoreceptor IS and in the OPL, INL and GCL (A, C, E). The double immunolabeling 
for FKRP and GM130 revealed colocalization in the photoreceptor IS, INL and GCL (E-G, arrowheads), whereas the double immunostaining 
for FKRP and β-DG showed colocalization in the OPL (J; yellow). Asterisks in D and I indicate non-specific immunostaining of retinal 
vessels by secondary anti-mouse IgG. Abbreviations are given in the legend of Figure 2. Each bar equals 20 μm (A-E), 10 μm (F-I) or 1 
μm (J, inset). 
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cultured cells, fukutin expression has been evidenced endog-
enously in human lymphoblasts and various established cell 
lines of different origins [55,62-64]. In this work, fukutin 
was detected by immunoblotting in both cytoplasmic and 
nuclear fractions of the adult mouse retina and of 661W cells, 
exhibiting an apparent molecular mass of 60 kDa. This was 
higher than the mass calculated from its amino acid sequence 
(54 kDa) or that reported in the mammalian brain and muscle 
and in HeLa cells [62,64], although consistent with the size 
reported by other authors in a wide list of human organs 
[54,55] and cell lines [55,63]. Such a discrepancy could be 
explained in terms of alternative processing of the FKTN gene 
mRNA, which has been reported to be quite an extensive 
phenomenon, at least in humans [27,62], and also possibly in 
terms of post-translational modification(s), such as glycosyl-
ation, hitherto unknown for this protein.
The FKRP gene has been seen expressed in several 
organs, with higher levels in skeletal muscle, placenta and 
heart [31], and, in this work, in the mammalian retina. We 
also detected the FKRP protein by immunoblotting in the 
cytoplasmic fraction of the mouse retina, as well as in both 
the cytoplasm and nucleus in 661W photoreceptors, in both 
cases with a molecular mass of 55 kDa compatible with that 
calculated from its amino acid sequence. At the protein level, 
FKRP has been found in human skeletal and cardiac muscle 
[39,40,65] and in mouse liver [35], as well as endogenously 
in a variety of established cell lines [39,65]. It follows that 
despite affecting mainly the brain and muscle, fukutin and 
FKRP are present in many other organs, where their function 
has not been addressed, including the retina, as shown in this 
work.
For both proteins, the results we have obtained by immu-
noblotting have been corroborated by confocal immunofluo-
rescence microscopy in mouse retinal sections and 661W 
photoreceptors. In this light, fukutin was detected in the 
cytoplasm of cells in all nuclear layers of the mouse retina, 
Figure 5. Immunolocalization of FKRP in the 661W photoreceptor cell line. Cells were immunostained with specific antibodies against 
FKRP (A, B, E; green) and the Golgi marker GM130 (D, E; red). Nuclei stained with DAPI are shown in blue (B). Enlarged views in C and 
F correspond to boxed areas in B and E, respectively. FKRP immunoreactivity was found in the cytoplasm and nucleus of 661W cells, and 
colocalized with GM130 in the cytoplasm (E, F; yellow). Each bar equals 20 μm, except in C and F: 5 μm,
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additionally accumulating in the nucleus of particular cell 
types (Figure 2). However, FKRP was found to be present 
as well in the cytoplasm of cells in all three retinal nuclear 
layers, but additionally in the OPL, and was excluded from 
the nucleus of all retinal cells (Figure 4). Regarding 661W 
photoreceptors, the presence of fukutin and FKRP in both 
the cytoplasm and nucleus detected by immunoblotting was 
ascertained by immunocytochemistry in this cell line (Figure 
3 and Figure 5, respectively).
We also evidenced a significant colocalization of fukutin 
with calreticulin in the mouse retina (Figure 2) and with 
KDEL in 661W cells (Figure 3), both two widely used ER 
markers. As well, we found colocalization of FKRP with the 
Golgi marker GM130 in both biological samples (Figure 4 
and Figure 5). On the other hand, no colocalization was seen 
between fukutin and GM130, or with FKRP with calreticulin 
or KDEL in either the retina or 661W cells. These results 
allow us to conclude that fukutin and FKRP are located in 
retinal cells, at least in part, in the ER and Golgi, respectively, 
at variance with the previous notion of both proteins residing 
in the Golgi, as reported for human skeletal muscle [39,40] 
and mouse liver [35], as well as endogenously in a wide 
variety of established cell lines [55,65]. In this context, it must 
be mentioned that fukutin has been detected in the ER, rather 
than in the Golgi, in cultures of human astrocytoma 1321N1 
and cervical carcinoma HeLa cell lines [55,56]. Hence, a 
scenario can be envisioned in which, in retinal neurons and 
661W photoreceptors, fukutin would attach in the ER the 
first unit of the phosphorylated pentose alcohol, Rbo5P, to 
the α-DG core M3 glycan, and FKRP would subsequently act 
in the Golgi to link the second Rbo5P molecule. An ensuing 
addition to the tandem Rbo5P acceptor of the Xyl/GlcA repeat 
by LARGE and other enzymes in this organelle would then 
generate the functional receptor for α-DG ECM ligands, 
i.e., the matriglycan structure [10], a process that remains 
to be investigated in the retina. Modulation of the intra-
cellular localization of fukutin and FKRP (i.e., ER versus 
Golgi) through tissue-dependent N-glycosylation has been 
suggested, based on their mislocalization being observed as 
a result of pathogenic mutations affecting particular sites of 
these proteins [35,62,66-68].
In the mouse retina, both proteins were also visualized in 
the OPL as distributing in a dotted pattern, with fukutin colo-
calizing with calreticulin (Figure 2) and FKRP colocalizing 
with β-DG (Figure 4). In this layer, they could be anchored 
to the presynaptic membrane of photoreceptors cells, or even 
secreted into the ECM of the synaptic cleft. This possibility 
cannot be ruled out since fukutin has been detected in the 
culture medium of COS-7 cells transfected with a human 
FKTN cDNA [26]. In addition, FKRP is known to be secreted 
into the extracellular medium by means of exocytic vesicles 
formed by the Golgi in transfected CHO cells [68]. FKRP 
has also been reported in association with the DGC at the 
sarcolemma in the mouse, suggesting a new function for this 
protein at the skeletal muscle membrane [69].
In addition to their localization in the ER (fukutin) and 
Golgi complex (FKRP), we found that both fukutin and 
FKRP were located in the nuclear fraction of 661W photo-
receptors, and fukutin as well in the nuclear fraction from 
the mouse retina, although at a higher abundancy in the cell 
line (Figure 1). These results were corroborated by immuno-
fluorescence microscopy, thus revealing the presence of both 
proteins in the nucleus of 661W cells (Figure 3 and Figure 
5), and of fukutin also in the nucleus of several cells in the 
INL and GCL of the mouse retina (Figure 2). The nuclear 
concentration of these proteins in 661W photoreceptors could 
be attributable to their absence of normal cell polarity, which 
is derived from their lack of outer segments and interaction 
with RPE cells. This loss of polarity has been posited to 
cause misplacement of some proteins with respect to their 
normal location in the retina, as is the case for red/green and 
blue cone opsins [48] and the ceramide kinase-like protein, 
CERKL [70]. In addition, unlike photoreceptors in the retina, 
661W is an immortalized cell line with an unlimited capacity 
for cell division [47]. Yet, it must be emphasized that this 
is not the first time that DGP-associated proteins have been 
detected in the nucleus of given cell types or established cell 
lines. Indeed, we have recently reported the accumulation of 
POMGNT1 in the nucleus of 661W cells, where it colocalized 
with POMT1 and POMT2, and these two proteins in turn 
with euchromatin areas [50]. Fukutin has also been found to 
be present in both the cytoplasm and the nucleus of human 
1321N1 and HeLa cell lines [55,56], and of most neurons 
of the human adult brain, both excitatory and inhibitory, 
including the cerebral cortex and cerebellum, where it coex-
ists with glycosylated α-DG [61]. Though highly speculative, 
the possibility thus exists that α-DG or other nuclear proteins 
could act as a substrate for both fukutin and FKRP, as well 
as for other DGP-associated glycosyltransferases, as we 
have recently proposed [50]. Yet, it cannot be ruled out that 
fukutin and FKRP could play in the nucleus roles that still 
need to be unraveled, which may or not be related to α-DG 
glycosylation, such as the modulation of cell proliferation, as 
suggested by other authors for fukutin [55,56,61] and by our 
group for POMGNT1 [50]. This is an issue that merits further 
investigation.
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APPENDIX 1. STR ANALYSIS
STR analysis of the 661W cell line. To access the data, click 
or select the words “Appendix 1”
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